Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Ravenna L"'
Autor:
Matos, Ravenna L., Vieira de Melo, Silvio A.B., Cabral Albuquerque, Elaine C.M., Foster, Neil R.
Publikováno v:
In Chemical Engineering and Processing - Process Intensification June 2019 140:64-77
Autor:
Verônica J. Pereira, Fabio P. Nascimento, Deividson S. Santos, Ravenna L. Matos, Gloria M. N. Costa, Silvio A. B. Vieira de Melo, Ying Guo
Publikováno v:
Blue Economy ISBN: 9789811950643
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::701b4ad80dc42de0dd8489776165ca62
https://doi.org/10.1007/978-981-19-5065-0_7
https://doi.org/10.1007/978-981-19-5065-0_7
Autor:
Silvio A.B. Vieira de Melo, Neil R. Foster, Elaine Christine de Magalhães Cabral Albuquerque, Ravenna L. Matos
Publikováno v:
Chemical Engineering and Processing - Process Intensification. 140:64-77
Dense carbon dioxide technology is promising for the processing of drug compounds and development of varied pharmaceutical formulations through micronization, coprecipitation, encapsulation and coating techniques. The main advantages of this technolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::34e33674e33d9bea42d45a8c542b9315
https://doi.org/10.1016/j.cep.2019.04.009
https://doi.org/10.1016/j.cep.2019.04.009
Autor:
Andrew Ingram, Christopher F McConville, Ravenna L. Matos, Tiejun Lu, Valentina Prosapio, Gary A. Leeke
Publikováno v:
Journal of CO2 Utilization. 30:48-62
The poor solubility of curcumin (CURC) in aqueous media leads to a low bioavailability, which prevents its application in pharmaceutical formulations. In this work, the Supercritical Antisolvent process (SAS) was used to produce coprecipitates of CUR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b35f0008c348feef0025710c488f9c34
https://doi.org/10.1016/j.jcou.2019.01.005
https://doi.org/10.1016/j.jcou.2019.01.005
Autor:
Qingguo Li, Yisheng Lin, Xiaodong Zhuang, Liu Liuyi, Tianhui Yuan, Ravenna L. Matos, Hongling He, Cuiping Jiang, Tingting Chen, Lei Zhang, Zhimin Ma, Tiejun Lu
Publikováno v:
International journal of pharmaceutics. 589
Directly coating an active pharmaceutical ingredient (API) onto excipient granules has been a common approach to prepare solid dosage forms. The combination of supercritical anti-solvent (SAS) and fluidized bed (FB) coating technology (SAS-FB) has th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c2812d3654cd8d595df2420ab05e858
https://pubmed.ncbi.nlm.nih.gov/32896606
https://pubmed.ncbi.nlm.nih.gov/32896606
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Valentina Prosapio, Tiejun Lu, Gary A. Leeke, Ravenna L. Matos, Andrew Ingram, Christopher F McConville
Publikováno v:
The Journal of Supercritical Fluids. 159:104758
Common strategies to improve the dissolution properties of hydrophobic drug compounds include the preparation of composites with hydrophilic excipients and/or size reduction. However, nanoparticles have poor flowability and difficult handling. Theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9b8b160b54398f2c003ace8ec298b66
https://doi.org/10.1016/j.supflu.2020.104758
https://doi.org/10.1016/j.supflu.2020.104758
Autor:
Tafani M, Pucci B, Russo A, Schito L, Pellegrini L, Perrone GA, Villanova L, Salvatori L, Ravenna L, Petrangeli E, Russo MA.
Publikováno v:
Symposia on frontiers of pharmacology 12 (2013): 4–13.
info:cnr-pdr/source/autori:Tafani M, Pucci B, Russo A, Schito L, Pellegrini L, Perrone GA, Villanova L, Salvatori L, Ravenna L, Petrangeli E, Russo MA./titolo:Modulators of HIF1? and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?/doi:/rivista:Symposia on frontiers of pharmacology/anno:2013/pagina_da:4/pagina_a:13/intervallo_pagine:4–13/volume:12
info:cnr-pdr/source/autori:Tafani M, Pucci B, Russo A, Schito L, Pellegrini L, Perrone GA, Villanova L, Salvatori L, Ravenna L, Petrangeli E, Russo MA./titolo:Modulators of HIF1? and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?/doi:/rivista:Symposia on frontiers of pharmacology/anno:2013/pagina_da:4/pagina_a:13/intervallo_pagine:4–13/volume:12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::14ea207c1f83393f9a2705928d281f3e
http://www.cnr.it/prodotto/i/276574
http://www.cnr.it/prodotto/i/276574
Autor:
Ravenna L, Sale P, Di Vito M, Russo A, Salvatori L, Tafani M, Mari E, Sentinelli S, Petrangeli E, Gallucci M, Di Silverio F, Russo MA.
Publikováno v:
The Prostate
69 (2009): 1245–1255.
info:cnr-pdr/source/autori:Ravenna L, Sale P, Di Vito M, Russo A, Salvatori L, Tafani M, Mari E, Sentinelli S, Petrangeli E, Gallucci M, Di Silverio F, Russo MA./titolo:Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma./doi:/rivista:The Prostate (Print)/anno:2009/pagina_da:1245/pagina_a:1255/intervallo_pagine:1245–1255/volume:69
69 (2009): 1245–1255.
info:cnr-pdr/source/autori:Ravenna L, Sale P, Di Vito M, Russo A, Salvatori L, Tafani M, Mari E, Sentinelli S, Petrangeli E, Gallucci M, Di Silverio F, Russo MA./titolo:Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma./doi:/rivista:The Prostate (Print)/anno:2009/pagina_da:1245/pagina_a:1255/intervallo_pagine:1245–1255/volume:69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::baf8b14fb61eb3660021ea92c37c750a
http://www.cnr.it/prodotto/i/11767
http://www.cnr.it/prodotto/i/11767